(Q46990390)

27 December 2017

title

Why alpha-antiplasmin must be converted to a derivative form for optimal function (English)

1 reference

27 December 2017

author name string

Lee KN

1

1 reference

27 December 2017

Jackson KW

2

1 reference

27 December 2017

Christiansen VJ

3

1 reference

27 December 2017

Lee CS

4

1 reference

27 December 2017

Chun JG

5

1 reference

27 December 2017

McKee PA

6

1 reference

27 December 2017

publication date

1 October 2007

1 reference

27 December 2017

Journal of Thrombosis and Haemostasis

published in

1 reference

27 December 2017

volume

5

1 reference

27 December 2017

issue

10

1 reference

27 December 2017

page(s)

2095-2104

1 reference

27 December 2017

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

The primary inhibitor of plasmin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Organization of the human alpha 2-plasmin inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02707.X

10.1111/J.1538-7836.2007.02707.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

17883704

1 reference

27 December 2017